Persistent bacteraemia caused by a single clone of Burkholderia cepacia with unusual phenotype

Journal of Infection

Volumn 42, Issue 3, 2001, Pages 202-205

  Teng, Lee Jene ^a,b   Hsueh, Po Ren ^b   Pan, Hui Ju ^b   Ho, Shen Wu ^a,b   Luh, Kwen Tay ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTINEOPLASTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; CYTARABINE; ETOPOSIDE; FATTY ACID; MITOXANTRONE; PIPERACILLIN; RIBOSOME DNA; TOBRAMYCIN; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; CASE REPORT; CHEMICAL ANALYSIS; CLONE; CONTROLLED STUDY; GENE AMPLIFICATION; GENOME; HUMAN; MALE; NEUTROPENIA; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0034906187     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2001.0825     Document Type: Article

References (18)

1. Burkholderia cepacia: Medical, taxonomic and ecological issues
2. An outbreak of Burkholderia cepacia with septicemia on a cardiology ward
3. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis
4. Burkholderia cepacia bacteremia: A retrospective analysis of 70 episodes
5. In vitro activities of antimicrobial agents, alone and in combination, against Burkholderia cepacia isolated from blood
6. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates
7. Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices
8. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis
9. Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli
10. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis
11. Severe Burkholderia (Pseudomonas) gladioli infections in chronic granulomatous disease: Report of two successfully treated cases
12. Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers
13. Identification of clinically isolates of gram-negative nonfermentative bacteria by an automated cellular fatty acid identification system
14. Multi-resistant isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis
15. Pneumonia caused by a newly recognized pseudomonad in a child with chronic granulomatous disease
16. Subgrouping of Pseudomonas cepacia by cellular fatty acid composition
17. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis analysis by randomly amplified polymorphic DNA finger-printing
18. Analysis of strains of Burkholderia (Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing